Xenia Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.20 M
- Paid Up Capital ₹ 0.90 M
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2018
- Revenue Growth 1250.98%
- Profit Growth 84.91%
- Ebitda 33.09%
- Net Worth -47.55%
- Total Assets 29.06%
About Xenia Pharma
Xenia Pharma Private Limited (XPPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 March 2015 (Nine years and ten months 16 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 1.20 M and a paid-up capital of Rs 0.90 M, as per Ministry of Corporate Affairs (MCA) records.
Vaidyanathan Viswanath, Remya, and Sathishkumar serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2015PTC262963
-
Company No.
262963
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Mar 2015
-
Date of AGM
29 Sep 2018
-
Date of Balance Sheet
31 Mar 2018
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Xenia Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sathishkumar
|
Managing Director | 25-Mar-2015 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Vaidyanathan Viswanath
|
Director | 25-Mar-2015 | Current |
|
Remya
|
Director | 25-Mar-2015 | Current |
Financial Performance of Xenia Pharma.
Xenia Pharma Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 1250.98% increase. The company also saw a substantial improvement in profitability, with a 84.91% increase in profit. The company's net worth observed a substantial decline by a decrease of 47.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Xenia Pharma?
In 2017, Xenia Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Xenia Pharma?
Unlock and access historical data on people associated with Xenia Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Xenia Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xenia Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.